Talala相关文献与解析，生知库 | 链接生命科学的每一步

Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

良性系统性前列腺活检结果后，前列腺特异性抗原密度与前列腺癌死亡率的相关性

期刊:Bju International

影响因子:4.4

doi:10.1111/bju.16641

Pylväläinen, Juho; Talala, Kirsi; Raitanen, Jani; Rannikko, Antti; Auvinen, Anssi

SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients

CYP2C9 和 VKORC1 基因的 SNP 基因型不影响芬兰前列腺癌患者服用华法林后罹患前列腺癌或癌症死亡率。

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0329438

Murtola, Teemu J; Skantsi, Kaisa M; Siltari, Aino; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo L J; Schleutker, Johanna; Auvinen, Anssi; Sipeky, Csilla

Model-based trends in the estimated number of children affected by maternal cancer diagnosis or death in Finland in 1968-2022

基于模型的芬兰1968-2022年受孕产妇癌症诊断或死亡影响的儿童人数估计趋势

期刊:Acta Oncologica

影响因子:2.2

doi:10.2340/1651-226X.2025.44072

Talala, Kirsi M; Mäkinen, Eetu E; Seppä, Karri J M; Lallukka, Tea M; Pitkäniemi, Janne M

Allopurinol and prostate cancer survival in a Finnish population-based cohort

别嘌醇与芬兰人群队列研究中前列腺癌生存率的关系

期刊:Prostate Cancer and Prostatic Diseases

影响因子:5.8

doi:10.1038/s41391-022-00597-4

Kukko, Ville; Kaipia, Antti; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo L J; Auvinen, Anssi; Murtola, Teemu J

Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

筛查史与前列腺癌死亡风险：芬兰前列腺癌筛查随机研究（FinRSPC）筛查组中的嵌套病例对照研究

期刊:Cancer Causes & Control

影响因子:2.1

doi:10.1007/s10552-023-01828-2

Talala, Kirsi; Walter, Stephen; Taari, Kimmo; Tammela, Teuvo L J; Kujala, Paula; Auvinen, Anssi

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer

前列腺特异性抗原低于 3 ng/mL 的男性前列腺癌发病率：芬兰前列腺癌筛查随机研究

期刊:International Journal of Cancer

影响因子:4.7

doi:10.1002/ijc.34274

Ola, Idris Olasunmbo; Talala, Kirsi; Tammela, Teuvo; Taari, Kimmo; Murtola, Teemu; Kujala, Paula; Raitanen, Jani; Auvinen, Anssi

Outcomes of Screening for Prostate Cancer Among Men Who Use Statins

服用他汀类药物的男性接受前列腺癌筛查的结果

期刊:Jama Oncology

影响因子:20.1

doi:10.1001/jamaoncol.2021.5672

Vettenranta, Arla; Murtola, Teemu J; Raitanen, Jani; Raittinen, Paavo; Talala, Kirsi; Taari, Kimmo; Stenman, Ulf-Håkan; Tammela, Teuvo L J; Auvinen, Anssi

Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer

在芬兰前列腺癌筛查随机研究中，抗癫痫药物使用者与未使用者相比，前列腺癌特异性死亡率如何？

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/s41416-022-01817-3

Salminen, Jukka K; Mehtola, Aino; Talala, Kirsi; Taari, Kimmo; Mäkinen, Jussi; Peltola, Jukka; Tammela, Teuvo L J; Auvinen, Anssi; Murtola, Teemu J

Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level

他汀类药物使用与癌症死亡率呈负相关，这与胆固醇水平有关。

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers14122920

Peltomaa, Antti I; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo L J; Auvinen, Anssi; Murtola, Teemu J

Risk factors for low-risk prostate cancer: A retrospective cohort study within the FinRSPC trial

低风险前列腺癌的危险因素：FinRSPC试验中的一项回顾性队列研究

Association of prostate-specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

良性系统性前列腺活检结果后，前列腺特异性抗原密度与前列腺癌死亡率的相关性

SNP genotypes in CYP2C9 and VKORC1 genes do not affect prostate cancer or cancer mortality among warfarin users in Finnish prostate cancer patients

CYP2C9 和 VKORC1 基因的 SNP 基因型不影响芬兰前列腺癌患者服用华法林后罹患前列腺癌或癌症死亡率。

Model-based trends in the estimated number of children affected by maternal cancer diagnosis or death in Finland in 1968-2022

基于模型的芬兰1968-2022年受孕产妇癌症诊断或死亡影响的儿童人数估计趋势

Allopurinol and prostate cancer survival in a Finnish population-based cohort

别嘌醇与芬兰人群队列研究中前列腺癌生存率的关系

Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC)

筛查史与前列腺癌死亡风险：芬兰前列腺癌筛查随机研究（FinRSPC）筛查组中的嵌套病例对照研究

Prostate cancer incidence in men with prostate-specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer

前列腺特异性抗原低于 3 ng/mL 的男性前列腺癌发病率：芬兰前列腺癌筛查随机研究

Outcomes of Screening for Prostate Cancer Among Men Who Use Statins

服用他汀类药物的男性接受前列腺癌筛查的结果

Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer

在芬兰前列腺癌筛查随机研究中，抗癫痫药物使用者与未使用者相比，前列腺癌特异性死亡率如何？

Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level

他汀类药物使用与癌症死亡率呈负相关，这与胆固醇水平有关。